Religare Enterprises Results Update

Religare Enterprises Business Update

Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.

Religare Enterprises Board Meeting Date

Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.

Religare Enterprises Credit Rating

Religare Enterprises disclosed that CRISIL upgraded credit ratings for its subsidiary Religare Broking's Rs. 500 Crore bank facilities. Long-term rating moved to BBB+/Stable and short-term to A2+.

Religare Enterprises Debt & Borrowing: ₹150 Cr

Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.

Value

₹150.0 Cr

Religare Enterprises Management Change

Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.

Religare Enterprises Other Announcement

Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).

Mukka Proteins Results Update

Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.

Oman facility manufacturing capacity

37200.0 MTPA

Aztec Fluids & Machinery Results Update

Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.

Ramky Infrastructure Results Update

Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.

Striders Impex Results Update

Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.

Jaro Institute of Technology Management and Research Results Update

Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.

Tata Chemicals Results Update

Tata Chemicals' Q2FY27 standalone revenue rose 8% to ₹1,303 Cr, with EBITDA up 22%. Consolidated results show a ₹50 Cr loss after tax amid soda ash pricing pressure.